Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry. 2014

M E Work, and E M John, and I L Andrulis, and J A Knight, and Y Liao, and A M Mulligan, and M C Southey, and G G Giles, and G S Dite, and C Apicella, and H Hibshoosh, and J L Hopper, and M B Terry
Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032, USA.

BACKGROUND Oestrogen receptor (ER)- and progesterone receptor (PR)-negative (ER-PR-) breast cancer is associated with poorer prognosis compared with other breast cancer subtypes. High parity has been associated with an increased risk of ER-PR- cancer, but emerging evidence suggests that breastfeeding may reduce this risk. Whether this potential breastfeeding benefit extends to women at high risk of breast cancer remains critical to understand for prevention. METHODS Using population-based ascertained cases (n=4011) and controls (2997) from the Breast Cancer Family Registry, we examined reproductive risk factors in relation to ER and PR status. RESULTS High parity (≥3 live births) without breastfeeding was positively associated only with ER-PR- tumours (odds ratio (OR)=1.57, 95% confidence interval (CI), 1.10-2.24); there was no association with parity in women who breastfed (OR=0.93, 95% CI 0.71-1.22). Across all race/ethnicities, associations for ER-PR- cancer were higher among women who did not breastfeed than among women who did. Oral contraceptive (OC) use before 1975 was associated with an increased risk of ER-PR- cancer only (OR=1.32, 95% CI 1.04-1.67). For women who began OC use in 1975 or later there was no increased risk. CONCLUSIONS Our findings support that there are modifiable factors for ER-PR- breast cancer and that breastfeeding in particular may mitigate the increased risk of ER-PR- cancers seen from multiparity.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009864 Ontario A province of Canada lying between the provinces of Manitoba and Quebec. Its capital is Toronto. It takes its name from Lake Ontario which is said to represent the Iroquois oniatariio, beautiful lake. (From Webster's New Geographical Dictionary, 1988, p892 & Room, Brewer's Dictionary of Names, 1992, p391)
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D012098 Reproduction The total process by which organisms produce offspring. (Stedman, 25th ed) Human Reproductive Index,Human Reproductive Indexes,Reproductive Period,Human Reproductive Indices,Index, Human Reproductive,Indexes, Human Reproductive,Indices, Human Reproductive,Period, Reproductive,Periods, Reproductive,Reproductive Index, Human,Reproductive Indices, Human,Reproductive Periods
D001942 Breast Feeding The nursing of an infant at the breast. Breast Fed,Breastfed,Milk Sharing,Wet Nursing,Breast Feeding, Exclusive,Breastfeeding,Breastfeeding, Exclusive,Exclusive Breast Feeding,Exclusive Breastfeeding,Sharing, Milk
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002140 California State bounded on the east by Nevada and Arizona, on the south by Mexico and the Pacific Ocean on the south and west, and on the north by Oregon.
D003276 Contraceptives, Oral Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives

Related Publications

M E Work, and E M John, and I L Andrulis, and J A Knight, and Y Liao, and A M Mulligan, and M C Southey, and G G Giles, and G S Dite, and C Apicella, and H Hibshoosh, and J L Hopper, and M B Terry
November 2003, British journal of cancer,
M E Work, and E M John, and I L Andrulis, and J A Knight, and Y Liao, and A M Mulligan, and M C Southey, and G G Giles, and G S Dite, and C Apicella, and H Hibshoosh, and J L Hopper, and M B Terry
May 1992, Lancet (London, England),
M E Work, and E M John, and I L Andrulis, and J A Knight, and Y Liao, and A M Mulligan, and M C Southey, and G G Giles, and G S Dite, and C Apicella, and H Hibshoosh, and J L Hopper, and M B Terry
November 2009, European journal of cancer (Oxford, England : 1990),
M E Work, and E M John, and I L Andrulis, and J A Knight, and Y Liao, and A M Mulligan, and M C Southey, and G G Giles, and G S Dite, and C Apicella, and H Hibshoosh, and J L Hopper, and M B Terry
June 1992, British journal of cancer,
M E Work, and E M John, and I L Andrulis, and J A Knight, and Y Liao, and A M Mulligan, and M C Southey, and G G Giles, and G S Dite, and C Apicella, and H Hibshoosh, and J L Hopper, and M B Terry
February 2014, British journal of cancer,
M E Work, and E M John, and I L Andrulis, and J A Knight, and Y Liao, and A M Mulligan, and M C Southey, and G G Giles, and G S Dite, and C Apicella, and H Hibshoosh, and J L Hopper, and M B Terry
December 2022, Cancer causes & control : CCC,
M E Work, and E M John, and I L Andrulis, and J A Knight, and Y Liao, and A M Mulligan, and M C Southey, and G G Giles, and G S Dite, and C Apicella, and H Hibshoosh, and J L Hopper, and M B Terry
January 2008, Lancet (London, England),
M E Work, and E M John, and I L Andrulis, and J A Knight, and Y Liao, and A M Mulligan, and M C Southey, and G G Giles, and G S Dite, and C Apicella, and H Hibshoosh, and J L Hopper, and M B Terry
January 2015, Contemporary oncology (Poznan, Poland),
M E Work, and E M John, and I L Andrulis, and J A Knight, and Y Liao, and A M Mulligan, and M C Southey, and G G Giles, and G S Dite, and C Apicella, and H Hibshoosh, and J L Hopper, and M B Terry
April 2005, Indian journal of pathology & microbiology,
M E Work, and E M John, and I L Andrulis, and J A Knight, and Y Liao, and A M Mulligan, and M C Southey, and G G Giles, and G S Dite, and C Apicella, and H Hibshoosh, and J L Hopper, and M B Terry
March 1999, British journal of cancer,
Copied contents to your clipboard!